Filter Search


Europe


Location Summary Deadline
Germany Drug Discount Agreements From 01.12.2024 For Various Active Ingredients Within The Framework Of An Open House Procedure 2026-10-01
Denmark Supplier List Regarding. Capacity Development Course For Danida Fellowship Centers 2026-10-01
Denmark Kdleg.22 Playground Equipment 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ertugliflozin (a10bk04) Within The Framework Of A So-called Open-house Model. 2026-10-01
Ireland Provision Of IT Services Qualification Panel 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V (open House Model) - Drug 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a (8)/130c (1) Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone (n05ax13) And The Trade Name Trevicta® Within The Framework Of A So-called Open-house Model. 2026-10-01
Norway Bekkeløp Sundre - Entreprise 1 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Vildagliptin (a10bh02) Within The Framework Of A So-called Open-house Model. 2026-10-01
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Sections 130a (8)/130c (1) Sgb V For Medicinal Products Containing The Active Ingredient Iron(iii) Sodium Gluconate Complex (b03ac07) Within The Framework Of A So-called Open-house Model. 2026-10-01
Whats app